Note: Ingredients listed on restricted chemical lists
EC/CAS
9003-39-8
Name of the chemical
polyvinylpyrrolidone
Concentration
N/A
EC/CAS
7647-01-0
Name of the chemical
Hydrochloric acid
Concentration
N/A
EC/CAS
7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
N/A
EC/CAS
7727-37-9
Name of the chemical
Nitrogen N2
Concentration
Composition
General Information
Version
7.0
Revision date
2025-08-05
Product name
Melphalan Hydrochloride for Injection
Chemical name
4-[Bis(2-chloroethyl)amino]-L-Phenylalanine hydrochloride
1.2.1 Relevant identified uses
Palliative treatment of patients with multiple myeloma for whom oral therapy is not appropriate
Icons in SDS
Company Information
company name
Sagent Pharmaceuticals
Section 2
SECTION 2: Hazards identification
OSHA Classification
Hazard statements
Toxic by ingestion. See package insert for details. (c) Description of Hazards: May cause local tissue damage should extravasation occur, as well as bone marrow suppression, possible bleeding, possible anaphylaxis, is potentially mutagenic. May cause cancer, mutagenic effects, fetal harm in pregnancy, and may also produce allergic skin reactions. (d) Unknown Acute Toxicity: N/A
2.1 Classification of the substance or mixture
This product is classified as hazardous according to the OSHA Hazard Communication Standard. However, products that are subject to the labelling requirements of the Food and Drug Administration are exempt from the
